| Impact of the Everolimus-Eluting Stent on Stent ThrombosisA Meta-Analysis of 13 Randomized Trials U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ... Journal of the American College of Cardiology 58 (15), 1569-1577, 2011 | 322 | 2011 |
| Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy A Narula, R Mehran, G Weisz, GD Dangas, J Yu, P Généreux, E Nikolsky, ... European heart journal 35 (23), 1533-1540, 2014 | 286 | 2014 |
| High‐Intensity Interval Training for Patients With Cardiovascular Disease—Is It Safe? A Systematic Review MA Wewege, D Ahn, J Yu, K Liou, A Keech Journal of the American Heart Association 7 (21), e009305, 2018 | 204 | 2018 |
| Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014 J Chandrasekhar, G Dangas, J Yu, S Vemulapalli, S Suchindran, AN Vora, ... Journal of the American College of Cardiology 68 (25), 2733-2744, 2016 | 187 | 2016 |
| Gut flora and bacterial translocation in chronic liver disease J Almeida, S Galhenage, J Yu, J Kurtovic, SM Riordan World journal of gastroenterology: WJG 12 (10), 1493, 2006 | 174 | 2006 |
| Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS … J Yu, R Mehran, L Grinfeld, K Xu, E Nikolsky, BR Brodie, B Witzenbichler, ... Catheterization and Cardiovascular Interventions 85 (3), 359-368, 2015 | 157 | 2015 |
| Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial: An analysis from a … A Prasad, G Dangas, M Srinivasan, J Yu, BJ Gersh, R Mehran, GW Stone Catheterization and Cardiovascular Interventions 83 (3), 343-348, 2014 | 156 | 2014 |
| Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial) AI Larsen, DWT Nilsen, J Yu, R Mehran, E Nikolsky, AJ Lansky, A Caixeta, ... The American journal of cardiology 111 (5), 643-648, 2013 | 111 | 2013 |
| New insights into the risk factors of contrast-induced encephalopathy J Yu, G Dangas J Endovasc Ther 18 (4), 545-6, 2011 | 86 | 2011 |
| Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS … RH Mehta, J Yu, JP Piccini, JE Tcheng, ME Farkouh, J Reiffel, M Fahy, ... The American journal of cardiology 109 (6), 805-812, 2012 | 81 | 2012 |
| Mobile Phone Technologies in the Management of Ischemic Heart Disease, Heart Failure, and Hypertension: Systematic Review and Meta-Analysis P Indraratna, D Tardo, J Yu, K Delbaere, M Brodie, N Lovell, SY Ooi JMIR mHealth and uHealth 8 (7), e16695, 2020 | 73 | 2020 |
| Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing … E Nikolsky, R Mehran, GD Dangas, J Yu, H Parise, K Xu, SJ Pocock, ... The American journal of cardiology 109 (6), 831-838, 2012 | 73 | 2012 |
| Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial. P Tobbia, BR Brodie, B Witzenbichler, C Metzger, G Guagliumi, J Yu, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2013 | 70 | 2013 |
| Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial T Rakowski, D Dudek, A Dziewierz, J Yu, B Witzenbichler, G Guagliumi, ... EuroIntervention 8 (11), 1307-1314, 2013 | 57 | 2013 |
| B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial R Jarai, G Dangas, K Huber, K Xu, BR Brodie, B Witzenbichler, ... Circulation: Cardiovascular Interventions 5 (6), 813-820, 2012 | 56 | 2012 |
| Sex-based differences in cessation of dual-antiplatelet therapy following percutaneous coronary intervention with stents J Yu, U Baber, I Mastoris, G Dangas, S Sartori, PG Steg, DJ Cohen, ... JACC: Cardiovascular Interventions 9 (14), 1461-1469, 2016 | 50 | 2016 |
| Safety and Efficacy of High-Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionThe HORIZONS-AMI (Harmonizing … J Yu, R Mehran, GD Dangas, BE Claessen, U Baber, K Xu, H Parise, ... JACC: Cardiovascular Interventions 5 (12), 1231-1238, 2012 | 45 | 2012 |
| Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity U Baber, J Bander, R Karajgikar, K Yadav, A Hadi, K Theodoropolous, ... Thrombosis and haemostasis 110 (07), 118-123, 2013 | 42 | 2013 |
| High-intensity interval training for patients with coronary artery disease: Finding the optimal balance A Keech, K Holgate, J Fildes, P Indraratna, L Cummins, C Lewis, J Yu International Journal of Cardiology, 2019 | 39 | 2019 |
| Incidence and Impact of Totally Occluded Culprit Coronary Arteries in Patients Presenting With Non–ST-Segment Elevation Myocardial Infarction J Warren, R Mehran, J Yu, K Xu, ME Bertrand, DA Cox, AM Lincoff, ... The American journal of cardiology 115 (4), 428-433, 2015 | 38 | 2015 |
Roxana MehranMount Sinai School of Medicine在 mountsinai.org 的电子邮件经过验证
